Instituto Nacional De Salud Mental

Instituto Nacional De Salud Mental "Honorio Delgado - Hideyo Noguchi" company information, Employees & Contact Information

Bienvenidos a la cuenta oficial del Instituto Nacional de Salud Mental “Honorio Delgado - Hideyo Noguchi” del Ministerio de Salud del Perú. Somos una entidad pública especializada en Salud Mental, que innova, investiga, desarrolla y transfiere nuevas tecnologías a través de la docencia, capacitación, atención altamente especializada y propone normas que fortalecen la rectoría del Sector Salud y contribuyen al desarrollo de la población nacional con proyección internacional.
Looking for a particular Instituto Nacional De Salud Mental "Honorio Delgado - Hideyo Noguchi" employee's phone or email?

Instituto Nacional De Salud Mental "honorio Delgado - Hideyo Noguchi" Questions

News

Published on: 2025-10-27 16:14:51 - Fundação Cultural do Pará

Published on: 2025-10-27 16:14:51 Fundação Cultural do Pará

Ohio Retirement Fund Invests in Insmed Incorporated (INSM) - Yahoo Finance

Ohio Retirement Fund Invests in Insmed Incorporated (INSM) Yahoo Finance

Is INSM stock a defensive play in 2025 - July 2025 News Drivers & AI Enhanced Trade Execution Alerts - Trung tâm Dự báo KTTV quốc gia

Is INSM stock a defensive play in 2025 - July 2025 News Drivers & AI Enhanced Trade Execution Alerts Trung tâm Dự báo KTTV quốc gia

FERC Responds to ERO’s INSM Clarification Filing - RTO Insider

FERC Responds to ERO’s INSM Clarification Filing RTO Insider

Insmed Incorporated (INSM) Rallies After FDA Approves Brinsupri, Shares Jump 9% - Insider Monkey

Insmed Incorporated (INSM) Rallies After FDA Approves Brinsupri, Shares Jump 9% Insider Monkey

Goldman's 48 potential M&A candidates (INSM:NASDAQ) - Seeking Alpha

Goldman's 48 potential M&A candidates (INSM:NASDAQ) Seeking Alpha

Notable ETF Outflow Detected - XBI, ALNY, INSM, HALO - Nasdaq

Notable ETF Outflow Detected - XBI, ALNY, INSM, HALO Nasdaq

Here's Why Insmed Incorporated's (NASDAQ:INSM) CEO May Have Their Pay Bumped Up - simplywall.st

Here's Why Insmed Incorporated's (NASDAQ:INSM) CEO May Have Their Pay Bumped Up simplywall.st

Prevalence of anxiety disorders in Latin America: a systematic review and meta-analysis - The Lancet

Prevalence of anxiety disorders in Latin America: a systematic review and meta-analysis The Lancet

Insmed (INSM) Reported Impressive Results from the Phase 2 Trial of Its Inhalation Powder - Yahoo Finance

Insmed (INSM) Reported Impressive Results from the Phase 2 Trial of Its Inhalation Powder Yahoo Finance

How INSM stock performs during Fed tightening cycles - Trade Entry Summary & Free High Return Stock Watch Alerts - Trung tâm Dự báo KTTV quốc gia

How INSM stock performs during Fed tightening cycles - Trade Entry Summary & Free High Return Stock Watch Alerts Trung tâm Dự báo KTTV quốc gia

What Makes Insmed Incorporated (INSM) an Investment Bet? - Insider Monkey

What Makes Insmed Incorporated (INSM) an Investment Bet? Insider Monkey

Insmed (INSM) Reports Increased Losses But Reiterates 2025 Revenue Guidance - Yahoo Finance

Insmed (INSM) Reports Increased Losses But Reiterates 2025 Revenue Guidance Yahoo Finance

Volume Report: Is INSM stock a defensive play in 2025 - Trade Signal Summary & Short-Term High Return Ideas - Trung tâm Dự báo KTTV quốc gia

Volume Report: Is INSM stock a defensive play in 2025 - Trade Signal Summary & Short-Term High Return Ideas Trung tâm Dự báo KTTV quốc gia

Will Insmed (INSM) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance

Will Insmed (INSM) Report Negative Earnings Next Week? What You Should Know Yahoo Finance

Don't Overlook Insmed (INSM) International Revenue Trends While Assessing the Stock - Yahoo Finance

Don't Overlook Insmed (INSM) International Revenue Trends While Assessing the Stock Yahoo Finance

Strong Drug Development Momentum Lifted Insmed Incorporated (INSM) in Q2 - Yahoo Finance

Strong Drug Development Momentum Lifted Insmed Incorporated (INSM) in Q2 Yahoo Finance

Insmed Incorporated (INSM) Soars on Positive PAH Therapy Trial Results - Yahoo Finance

Insmed Incorporated (INSM) Soars on Positive PAH Therapy Trial Results Yahoo Finance

Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating - Yahoo Finance

Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating Yahoo Finance

Insmed Incorporated (INSM): Insiders Were Dumping in Q1 2025 - Yahoo Finance

Insmed Incorporated (INSM): Insiders Were Dumping in Q1 2025 Yahoo Finance

Should Insmed’s (INSM) EMA Nod for BRINSUPRI Prompt a Fresh Look at Its Growth Prospects? - Yahoo Finance

Should Insmed’s (INSM) EMA Nod for BRINSUPRI Prompt a Fresh Look at Its Growth Prospects? Yahoo Finance

Insmed (INSM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Insmed (INSM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates Yahoo Finance

Goldman Sachs Maintains Insmed (INSM) Buy Recommendation - Nasdaq

Goldman Sachs Maintains Insmed (INSM) Buy Recommendation Nasdaq

Insmed Incorporated (INSM): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying - Yahoo Finance

Insmed Incorporated (INSM): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying Yahoo Finance

Guru Fundamental Report for INSM - Benjamin Graham - Nasdaq

Guru Fundamental Report for INSM - Benjamin Graham Nasdaq

Wells Fargo Lifts Price Target on Insmed Incorporated (INSM) to $119 From $107 - Yahoo Finance

Wells Fargo Lifts Price Target on Insmed Incorporated (INSM) to $119 From $107 Yahoo Finance

Insmed (INSM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates - Nasdaq

Insmed (INSM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates Nasdaq

How FDA Approval of BRINSUPRI for NCFB at Insmed (INSM) Has Changed Its Investment Story - Yahoo Finance

How FDA Approval of BRINSUPRI for NCFB at Insmed (INSM) Has Changed Its Investment Story Yahoo Finance

Insider Sale: Director at $INSM Sells 10,000 Shares - Quiver Quantitative

Insider Sale: Director at $INSM Sells 10,000 Shares Quiver Quantitative

New Analyst Forecast: $INSM Given $193.0 Price Target | INSM Stock News - Quiver Quantitative

New Analyst Forecast: $INSM Given $193.0 Price Target | INSM Stock News Quiver Quantitative

Insmed (INSM) Gains As FDA Approves BRINSUPRI For New Market - simplywall.st

Insmed (INSM) Gains As FDA Approves BRINSUPRI For New Market simplywall.st

New Analyst Forecast: $INSM Given 'Outperform' Rating - Quiver Quantitative

New Analyst Forecast: $INSM Given 'Outperform' Rating Quiver Quantitative

What Does Wall Street Think About Insmed Incorporated (INSM)? - Insider Monkey

What Does Wall Street Think About Insmed Incorporated (INSM)? Insider Monkey

October 17th Options Now Available For Insmed (INSM) - Nasdaq

October 17th Options Now Available For Insmed (INSM) Nasdaq

Insmed Incorporated (INSM): Among Takeover Rumors Hedge Funds Are Buying - Yahoo Finance

Insmed Incorporated (INSM): Among Takeover Rumors Hedge Funds Are Buying Yahoo Finance

Insmed downgraded at Morgan Stanley despite FDA nod for lung therapy - Seeking Alpha

Insmed downgraded at Morgan Stanley despite FDA nod for lung therapy Seeking Alpha

TD Cowen Raises Price Target for Insmed (INSM) to $193 | INSM St - GuruFocus

TD Cowen Raises Price Target for Insmed (INSM) to $193 | INSM St GuruFocus

Insmed Announces Massive $650M Stock Offering with Goldman Sachs, Leerink as Underwriters - Stock Titan

Insmed Announces Massive $650M Stock Offering with Goldman Sachs, Leerink as Underwriters Stock Titan

Goldman Sachs Raises Insmed (INSM) Price Target to $196 | INSM S - GuruFocus

Goldman Sachs Raises Insmed (INSM) Price Target to $196 | INSM S GuruFocus

Noteworthy ETF Outflows: XBI, CRSP, RVMD, INSM - Nasdaq

Noteworthy ETF Outflows: XBI, CRSP, RVMD, INSM Nasdaq

Lung Disease-Focused Insmed 'Must-Own' Name For Investors - Benzinga

Lung Disease-Focused Insmed 'Must-Own' Name For Investors Benzinga

Insmed (INSM) Secures $750 Million Through Stock Offering - GuruFocus

Insmed (INSM) Secures $750 Million Through Stock Offering GuruFocus

Noteworthy Tuesday Option Activity: DXC, DK, INSM - Nasdaq

Noteworthy Tuesday Option Activity: DXC, DK, INSM Nasdaq

Insmed (INSM) Receives Price Target Increase from Wells Fargo | - GuruFocus

Insmed (INSM) Receives Price Target Increase from Wells Fargo | GuruFocus

Investing in Insmed (NASDAQ:INSM) five years ago would have delivered you a 308% gain - simplywall.st

Investing in Insmed (NASDAQ:INSM) five years ago would have delivered you a 308% gain simplywall.st

Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update - PR Newswire

Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update PR Newswire

Prevalence of depressive disorder in the adult population of Latin America: a systematic review and meta-analysis - The Lancet

Prevalence of depressive disorder in the adult population of Latin America: a systematic review and meta-analysis The Lancet

Propiedades psicométricas de la escala de salud mental positiva en Arequipa (Perú) - SciELO España

Propiedades psicométricas de la escala de salud mental positiva en Arequipa (Perú) SciELO España

INSM Stock Price and Chart — NASDAQ:INSM - TradingView

INSM Stock Price and Chart — NASDAQ:INSM TradingView

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant